Pfizer and BioNTech in mid-December announced that two doses of the vaccine, given at a tenth of the amount of an adult dosing, did not produce a strong enough immune response in children ages 2 to 4.
Published: January 31, 2022 at 01:00AM
from #NYT Science Read the full article here: https://ift.tt/Iwr0k4NvE